ViRexx Medical Corp. (TSX:VIR) (AMEX: REX) a company focused on immunotherapy treatments for cancer, chronic hepatitis B & C and embolotherapy treatments for tumours, today announced that Dr. Lorne Tyrrell, Chief Executive Officer and Chief Scientific Officer, will be presenting at BioFinance 2006 in Toronto, Ontario on Wednesday, May 3rd, 2006.
